ABVCX
Price
$18.43
Change
+$0.04 (+0.22%)
Updated
Aug 19 closing price
Net Assets
427.6M
VVIAX
Price
$70.65
Change
+$0.33 (+0.47%)
Updated
Aug 19 closing price
Net Assets
195.81B
Interact to see
Advertisement

ABVCX vs VVIAX

Header iconABVCX vs VVIAX Comparison
Open Charts ABVCX vs VVIAXBanner chart's image
AB Large Cap Value C
Price$18.43
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets427.6M
Vanguard Value Index Adm
Price$70.65
Change+$0.33 (+0.47%)
VolumeN/A
Net Assets195.81B
ABVCX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ABVCX vs. VVIAX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVCX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. ABVCX (428M). VVIAX pays higher dividends than ABVCX: VVIAX (2.18) vs ABVCX (0.05). ABVCX was incepted earlier than VVIAX: ABVCX (24 years) vs VVIAX (25 years). ABVCX (1.65) is less costly to investors than VVIAX (0.05). ABVCX is a more actively managed with annual turnover of: 53.00 vs. VVIAX (9.00). ABVCX has a lower initial minimum investment than VVIAX: ABVCX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.59 vs. ABVCX (-1.03). VVIAX return over 5 years is better than : 70.19 vs. ABVCX (38.46).
ABVCXVVIAXABVCX / VVIAX
Total Expense Ratio1.650.053,300%
Annual Report Gross Expense Ratio1.650.053,300%
Fund Existence24 years25 years-
Gain YTD6.7176.532103%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets428M196B0%
Annual Yield % from dividends0.052.182%
Returns for 1 year-1.037.59-14%
Returns for 3 years7.3527.0327%
Returns for 5 years38.4670.1955%
Returns for 10 years39.87127.4531%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRCA6.160.20
+3.27%
Verrica Pharmaceuticals Inc
ARCB71.830.37
+0.52%
ArcBest Corp
FVNNU10.50-0.04
-0.38%
Future Vision II Acquisition Corp.
AM17.55-0.36
-2.01%
Antero Midstream Corp
CAPR7.70-0.27
-3.39%
Capricor Therapeutics